Outi Kuittinen
Professor
Head of the Discipline
Institute of Clinical Medicine, School of Medicine, Faculty of Health Sciences
outi.kuittinen@uef.fi
Research groups
Publications
49 items-
Blood–Brain Barrier Disruption (BBBD)-Based Immunochemotherapy for Primary Central Nervous System Lymphoma (PCNSL), Early Results of a Phase II Study
Kuitunen, Hanne K; Rönkä, Aino LK; Sonkajärvi, Eila M; Isokangas, Juha-Matti; Pyörälä, Marja; Palosaari, Kari AA; Jokimäki, Anna S; Partanen, Anu E; Littow, Harri J; Vakkala, Merja A; Jantunen, Esa J; Huttunen, Mirja E; Marin, Katja J; Aromaa-Häyhä, Annikki MK; Auvinen, Päivi K; Selander, Tuomas; Puhakka, Inka K; Kuittinen, Outi M. 2023. Cancers. 15: -
CD34(+) Cell Mobilization, Autograft Cellular Composition and Outcome in Mantle Cell Lymphoma Patients
Turunen, Antti Samuli; Kuittinen, Outi; Kuitunen, Hanne; Vasala, Kaija; Penttila, Karri; Harmanen, Minna; Keskinen, Leena; Mantymaa, Pentti; Pelkonen, Jukka; Varmavuo, Ville; Jantunen, Esa; Partanen, Anu. 2023. Transfusion medicine and hemotherapy. 50: 428-437 -
Controversies in the Front-Line Treatment of Systemic Peripheral T Cell Lymphomas
Sorigue, Marc; Kuittinen, Outi. 2023. Cancers. 15: -
Estimating the Lifetime Treatment Burden of Patients With Follicular Lymphoma: A Retrospective Study Using Real-World Multicenter Data
Rajamäki, Aino; Hujo, Mika; Sund, Reijo; Prusila, Roosa E.I.; Kuusisto, Milla E.L.; Kuitunen, Hanne; Jantunen, Esa; Mercadal, Santiago; Sorigue, Marc; Sancho, Juan Manuel; Sunela, Kaisa; Kuittinen, Outi. 2023. JCO clinical cancer informatics. 7: -
Follikulaarisen lymfooman muuttuva hoito
Aromaa-Häyhä, Annikki; Auvinen, Päivi; Marin, Katja; Prusila, Roosa; Jokelainen, Otto; Kuittinen, Outi. 2023. Duodecim. 139: 117-125 -
Loss of CD34+ Cells and Effect of the Number of Viable Cryopreserved CD34+ Cells in the Infused Blood Grafts on Hematologic Recovery, Progression-Free Survival and Overall Survival in NHL Patients After Autologous Stem Cell Transplantation
Partanen, Anu; Turunen, Antti; Valtola, Jaakko; Pyörälä, Marja; Kuittinen, Outi; Kuitunen, Hanne; Vasala, Kaija; Penttilä, Karri; Kuittinen, Taru; Mäntymaa, Pentti; Pelkonen, Jukka; Jantunen, Esa; Varmavuo, Ville. 2023. Clinical lymphoma myeloma and leukemia. 23: e428-e435 -
Lymfoomien patologisanatominen diagnostiikka
Kuittinen, Outi; Aromaa-Häyhä, Annikki; Böhm, Jan; Hämäläinen, Kirsi; Jyrkkiö, Sirkku; Karjalainen-Lindsberg, Marja-Liisa; Leppä, Sirpa; Pollari, Marjukka; Vaittinen, Samuli; Vasala, Kaija; Vornanen, Martine; Kauppila, Saila. 2023. Duodecim. 139: 107-116 -
Previous radiotherapy improves treatment responses and causes a trend toward longer time to progression among patients with immune checkpoint inhibitor-related adverse events
Jokimäki, Anna; Hietala, Henna; Lemma, Jasmiini; Karhapää, Hanna; Rintala, Anna; Kaikkonen, Jari-Pekka; Sunela, Kaisa; Boman, Eva; Jukkola, Arja; Tiainen, Satu; Seppälä, Jan; Rönkä, Aino; Hakkarainen, Heikki; Kärnä, Aarno; Iivanainen, Sanna; Koivunen, Jussi; Auvinen, Päivi; Hernberg, Micaela; Kuusisto, Milla; Selander, Tuomas; Kuittinen, Outi. 2023. Cancer immunology immunotherapy. 72: 3337-3347 -
R-bendamustine in the treatment of nodular lymphocyte predominant Hodgkin lymphoma-An extended follow-up
Vuolio, Tero; Kuittinen, Outi; Vayrynen, Juha P; Teppo, Hanna-Riikka; Prusil, Roosa EI; Ramet, Maria; Kuitunen, Hanne; Paloneva, Timo; Kuusisto, Milla EL. 2023. British journal of haematology. 202: e24-e26 -
Rapid diagnosis and initiation of treatment has a crucial role in the prognosis of primary central nervous system lymphoma
Kuitunen, Hanne; Puhakka, Inka; Ronka, Aino; Selander, Tuomas; Jakala, Pekka; Arkko, Ulla-Mari; Klaavuniemi, Tuula; Sunela, Kaisa; Rajamaki, Aino; Kuittinen, Outi. 2023. British journal of haematology. 203: e78-e81